$18.01 -0.28 (-1.53%)
11/27/2009 1:00 PM

Mylan Laboratories, Inc. (MYL)

CAPS Rating: 3 out of 5

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

Results 1 - 20 of 92 1 2 3 4 5 Next »

Recs

0
Member Avatar stockfreak1 (< 20) Submitted: 11/13/2009 3:16:04 PM : Underperform Start Price: $17.54 MYL Score: -2.51

If this stock actually gave me points I would upthumb it.

Recs

0
Member Avatar bobsweet (30.42) Submitted: 9/28/2009 9:17:38 AM : Outperform Start Price: $16.15 MYL Score: +7.02

Love the company. Generic medicine will boost with Obamas healtcare plan. Not to mention new FDA approvals, including HIV pill approval. I am just waiting for this comapny to explode!!!!

Recs

0
Member Avatar dutchredneck (42.60) Submitted: 9/23/2009 10:30:55 AM : Outperform Start Price: $16.11 MYL Score: +9.45

Growth stock will outperform the S&P.

Recs

0
Member Avatar 8tune (63.49) Submitted: 9/9/2009 1:46:27 PM : Outperform Start Price: $14.27 MYL Score: +20.17

Mylan generic pharma to outperform S&P.

Recs

0
Member Avatar NOFY (60.06) Submitted: 8/10/2009 10:25:26 AM : Outperform Start Price: $13.27 MYL Score: +26.72

Baby boomers, many drugs going generic soon.

Recs

0
Member Avatar clarkrl2 (61.83) Submitted: 8/9/2009 2:30:53 AM : Outperform Start Price: $13.30 MYL Score: +26.13

I think generic drug companies will not be adversely affected buy any new healthcare legislation. The stock has an MSN stock scouter rating of 9 and I think it has the potential to double.

Recs

0
Member Avatar gorfo57 (< 20) Submitted: 8/3/2009 12:57:03 PM : Outperform Start Price: $13.45 MYL Score: +24.25

Solid generic drug company.

Recs

0
Member Avatar gpag0nz (24.84) Submitted: 7/29/2009 6:03:47 PM : Outperform Start Price: $13.30 MYL Score: +24.02

Low hanging fruit ready for picking by large drug company with available funds. Probable price $20.

Recs

0
Member Avatar MightyPeepAnt (91.55) Submitted: 4/16/2009 7:44:56 AM : Outperform Start Price: $14.25 MYL Score: -2.45

New generics being produced of high need drugs.

Recs

0
Member Avatar stevez24 (79.81) Submitted: 3/26/2009 11:25:30 AM : Outperform Start Price: $13.59 MYL Score: -2.35

obama health plan increases use of generics

Recs

0
Member Avatar Jivy2008 (65.13) Submitted: 3/17/2009 5:53:51 PM : Outperform Start Price: $13.37 MYL Score: -8.60

Beating the S&P right now!

Recs

0
Member Avatar lvelez (< 20) Submitted: 3/13/2009 4:47:52 PM : Outperform Start Price: $13.17 MYL Score: -8.14

I like it!

Recs

0
Member Avatar ipfmanager (97.95) Submitted: 2/23/2009 11:04:53 AM : Outperform Start Price: $10.78 MYL Score: +33.68

It's rare when you can recommened a stock for 5 different reasons:

1. Baby Boomer Play
2. Lack of Brand Name pipleline play
3. Obama Play
4. Takeover target (teva) play
5. Skewered balance sheet from recent takeover play.

Recs

0
Member Avatar Tyrone85 (98.10) Submitted: 2/19/2009 9:57:09 PM : Outperform Start Price: $11.98 MYL Score: +4.96

march,2009

Recs

0
Member Avatar bullmeover (< 20) Submitted: 2/9/2009 11:17:40 AM : Outperform Start Price: $11.88 MYL Score: +22.37

Health care reform will need generic drugs to make it fiscally feasible. MYL has acquired key products to position it in the market for growth or takeover.

Recs

0
Member Avatar biotech4ever (93.53) Submitted: 2/7/2009 10:48:03 PM : Outperform Start Price: $8.00 MYL Score: +106.40

Mylan and Teva are the best generic drug plays. With so many drugs coming off patents in the next 2-3 years these companies are really going to prosper. Don't listen to Jim Cramer about generic drugs, and I don't know what the hell that guy is thinking.

Recs

0
Member Avatar BERNARDVONSTARK (< 20) Submitted: 1/9/2009 5:46:15 PM : Outperform Start Price: $10.75 MYL Score: +42.02

Mylan management will gain crediblity each quarter they show they can handle and cash flow the debt load.

Recs

0
Member Avatar KWSBLS (< 20) Submitted: 1/8/2009 12:02:15 PM : Outperform Start Price: $10.36 MYL Score: +50.18

Mylan is proving to the investment community that it can cash flow with it's current debt structure. Every quarter they will gain more credibility and a higher stock price.

Recs

0
Member Avatar matu2009 (84.24) Submitted: 11/20/2008 3:43:48 AM : Outperform Start Price: $7.72 MYL Score: +93.00

Definitely a strong stock. People are going to really need this stuff soon so it's a good time to buy.

Recs

0
Member Avatar Theredlion (< 20) Submitted: 11/7/2008 11:25:45 AM : Outperform Start Price: $9.30 MYL Score: +71.07

company in a good position adn has multiple products available

Results 1 - 20 of 92 1 2 3 4 5 Next »

Featured Broker Partners